VERASONICS, INC

Verasonics, Inc. specializes in the design and manufacturing of advanced analytical laboratory instruments, with a demonstrated focus on high-precision ultrasound systems for preclinical neuroscience research. Their technical expertise centers on focused ultrasound technology tailored for in vivo brain imaging in awake, freely-moving rodents under dynamic behavioral conditions, enabling non-invasive, real-time neurophysiological data acquisition. This capability integrates signal processing, transducer array engineering, and real-time control systems to support cutting-edge neurobehavioral studies. Their instruments are engineered for reproducibility and environmental adaptability, distinguishing them in the niche market of translational neuroimaging platforms. The company has consistently partnered with the Department of Health and Human Services, delivering specialized laboratory equipment that supports biomedical research initiatives, particularly in neurology and behavioral science. Their engagement with HHS reflects a pattern of providing mission-critical instrumentation for controlled experimental environments, aligning with NIH-funded research objectives. Verasonics operates primarily within NAICS 334516, which encompasses the manufacturing of analytical laboratory instruments used in scientific and medical research. Their market positioning is defined by precision engineering for neuroscientific applications, serving academic, government, and pharmaceutical research sectors that require high-fidelity, non-invasive imaging tools. They are not a general-purpose equipment supplier but a focused provider of specialized systems for advanced neuroimaging workflows. As a small business structured as a 2L entity based in Kirkland, Washington, Verasonics maintains a lean, technically driven operational model. While no formal government certifications are disclosed, their ability to deliver complex, research-grade instrumentation under tight delivery timelines underscores a high level of technical maturity and responsiveness to federal research mandates. Their geographic proximity to major biomedical research hubs enhances their ability to collaborate with federal science agencies.